Atlas Trials

Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

Clinical trial NCT00406978 · COMPLETED

Trial details

NCT number
NCT00406978
Sponsor
Silvio Aime
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2006-02-01
Primary completion
2010-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.